http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112263585-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06 |
| filingDate | 2020-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112263585-B |
| titleOfInvention | Application of protopanaxadiol PPD in preparation of medicine for treating infertility and abortion |
| abstract | The invention belongs to the technical field of medicine, in particular to the application of protopanaxadiol PPD in the preparation of medicines for treating infertility and abortion. The present invention shows through in vitro experiments and in vivo animal experiments that protopanaxadiol PPD can significantly inhibit the expression of inflammatory factors in peritoneal macrophages, increase the expression of endometrial receptivity-related genes, increase the pregnancy rate, and increase the total number of embryos As well as reducing the embryo resorption rate, PPD does not have liver and kidney toxicity. Further, it can be used to prepare medicines for treating infertility and miscarriage related to inflammation and poor endometrial receptivity, has strong practicability, and can be well applied clinically. |
| priorityDate | 2020-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 347.